Science.Online
Publisher and Institutes
Akademie Verlag
Deutsches Institut für Urbanistik
Oldenbourg Wissenschaftsverlag
Walter de Gruyter
Schattauer
You are here: Home :: Area NEM :: Medical science :: Human medicine
 
Xiaohong Zhang, Matthias Frischmann, Rose Kientsch-Engel, Katharina Steinmann, Helga Stopper, Toshimitsu Niwa, Monika Pischetsrieder

Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients

Keywords: advanced glycation end-products, N ?-carboxymethyllysine (CML), enzyme-linked immunosorbent assay (ELISA), imidazolone, serum

Advanced glycation end-products are uremic toxins that accumulate in the serum and tissues of patients with chronic renal failure. Here, we established two enzyme-linked immunosorbent assays (ELISAs) for N ? -carboxymethyllysine and imidazolone to analyze advanced glycation end-products in human serum. Both ELISAs detected advanced glycation end-products bound to human serum albumin in a dose-dependent way. Whereas the formation of imida-zolone was independent of the presence of oxygen, concentrations of N ? -carboxymethyllysine epitopes increased 20-fold under oxidative conditions. The N ? -carboxymethyllysine ELISA showed a similar response to free, peptide-bound and protein-bound N ? -carboxymethyllysine, whereas the imidazolone antibody showed slightly higher affinity toward peptide-bound compared to protein-bound imidazolone. In human serum, linear dilution ranges from 1:10 to 1:40 (N ? -carboxymethyllysine ELISA) and from 1:2 to 1:8 (imidazolone ELISA) were found. The recovery of N ? -carboxymethyllysine from serum was 101±10% and 94±12%, respectively, and 93±15% and 97±12% for imidazolone. The coefficients of variation for intra-assay variability were 0.26–2.7% (N ? -carboxymethyllysine) and 0.1–2.4% (imidazolone), and 8.3–13.4% (N ? -carboxymethyllysine) and 7.8–12.5% (imidazolone) for inter-assay variability. In serum samples from hemodialysis patients (n=20) and controls (n=20), an approximately two-fold increase was detected in the patient group (p<0.001). The combination of the N ? -carboxymethyllysine and imidazolone ELISAs is a valuable tool to measure serum concentrations of advanced glycation end-products for clinical studies.

Clinical Chemical Laboratory Medicine, Walter de Gruyter

Print ISSN: 1434-6621
Volume: 43, 05/2005
Pages: 503 - 511

Show full article (external site)

Show all available items of this journal